A policy of omitting an intensive care unit stay after robotic pancreaticoduodenectomy is safe and cost-effective

Kellie E. Cunningham, Mazen S. Zenati, Jonathan R. Petrie, Jennifer L. Steve, Melissa E. Hogg, Herbert J. Zeh, Amer H. Zureikat

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Background Immediate postoperative admission to the intensive care unit (ICU) after pancreaticoduodenectomy (PD) is still a standard practice at many institutions. Our aim was to examine whether omission of an immediate postoperative ICU admission would be safe and result in improved outcomes and cost after robotic pancreaticoduodenectomy (RPD). Methods In December 2014, a non-ICU admission policy was implemented for patients undergoing RPD. Before this date, all RPDs were routinely admitted to the ICU on post operative day = 0. Using a prospective database, outcomes of the patients in the no-ICU cohort were compared with those of the patients routinely admitted to the ICU before implementation of this policy. Results The ICU (n = 49) and no-ICU cohorts (n = 47) were comparable in age, gender, body mass index, Charlson comorbidity index and American Society of Anesthesiologists scores, receipt of neoadjuvant therapy, operative time, estimated blood loss, tumor size, and pathologic diagnosis (all P values = NS). Clavien complications, pancreatic leak, reoperation, readmission, and mortality were similar between both the groups (all P values = NS). Hospital length of stay (LOS) was shorter for the no-ICU group (median 6.8 versus 7.7 d, P = 0.01). This reduced LOS and omission of routine postoperative ICU admission translated into a cost reduction from $23,933 (interquartile range $19,833-$28,991) in the ICU group to $19,516 (interquartile range $17,046-$23,893) in the no-ICU group, P = 0.004. The reduction in LOS and cost remained significant after adjusting for all related demographics and perioperative characteristics. Conclusions A standard policy of omitting a postoperative ICU admission on post operative day 0 after RPD is safe and can result in reduced LOS and overall savings in total hospital cost.

Original languageEnglish (US)
Pages (from-to)8-14
Number of pages7
JournalJournal of Surgical Research
Volume204
Issue number1
DOIs
StatePublished - Jul 1 2016
Externally publishedYes

Fingerprint

Pancreaticoduodenectomy
Robotics
Intensive Care Units
Costs and Cost Analysis
Length of Stay
Postoperative Care
Neoadjuvant Therapy
Hospital Costs
Operative Time
Reoperation
Comorbidity
Body Mass Index
Demography

Keywords

  • Cost
  • ICU
  • Pancreaticoduodenectomy
  • Robotic
  • Whipple

ASJC Scopus subject areas

  • Surgery

Cite this

A policy of omitting an intensive care unit stay after robotic pancreaticoduodenectomy is safe and cost-effective. / Cunningham, Kellie E.; Zenati, Mazen S.; Petrie, Jonathan R.; Steve, Jennifer L.; Hogg, Melissa E.; Zeh, Herbert J.; Zureikat, Amer H.

In: Journal of Surgical Research, Vol. 204, No. 1, 01.07.2016, p. 8-14.

Research output: Contribution to journalArticle

Cunningham, Kellie E. ; Zenati, Mazen S. ; Petrie, Jonathan R. ; Steve, Jennifer L. ; Hogg, Melissa E. ; Zeh, Herbert J. ; Zureikat, Amer H. / A policy of omitting an intensive care unit stay after robotic pancreaticoduodenectomy is safe and cost-effective. In: Journal of Surgical Research. 2016 ; Vol. 204, No. 1. pp. 8-14.
@article{22aab22083434e2bb23984e59b98b2ea,
title = "A policy of omitting an intensive care unit stay after robotic pancreaticoduodenectomy is safe and cost-effective",
abstract = "Background Immediate postoperative admission to the intensive care unit (ICU) after pancreaticoduodenectomy (PD) is still a standard practice at many institutions. Our aim was to examine whether omission of an immediate postoperative ICU admission would be safe and result in improved outcomes and cost after robotic pancreaticoduodenectomy (RPD). Methods In December 2014, a non-ICU admission policy was implemented for patients undergoing RPD. Before this date, all RPDs were routinely admitted to the ICU on post operative day = 0. Using a prospective database, outcomes of the patients in the no-ICU cohort were compared with those of the patients routinely admitted to the ICU before implementation of this policy. Results The ICU (n = 49) and no-ICU cohorts (n = 47) were comparable in age, gender, body mass index, Charlson comorbidity index and American Society of Anesthesiologists scores, receipt of neoadjuvant therapy, operative time, estimated blood loss, tumor size, and pathologic diagnosis (all P values = NS). Clavien complications, pancreatic leak, reoperation, readmission, and mortality were similar between both the groups (all P values = NS). Hospital length of stay (LOS) was shorter for the no-ICU group (median 6.8 versus 7.7 d, P = 0.01). This reduced LOS and omission of routine postoperative ICU admission translated into a cost reduction from $23,933 (interquartile range $19,833-$28,991) in the ICU group to $19,516 (interquartile range $17,046-$23,893) in the no-ICU group, P = 0.004. The reduction in LOS and cost remained significant after adjusting for all related demographics and perioperative characteristics. Conclusions A standard policy of omitting a postoperative ICU admission on post operative day 0 after RPD is safe and can result in reduced LOS and overall savings in total hospital cost.",
keywords = "Cost, ICU, Pancreaticoduodenectomy, Robotic, Whipple",
author = "Cunningham, {Kellie E.} and Zenati, {Mazen S.} and Petrie, {Jonathan R.} and Steve, {Jennifer L.} and Hogg, {Melissa E.} and Zeh, {Herbert J.} and Zureikat, {Amer H.}",
year = "2016",
month = "7",
day = "1",
doi = "10.1016/j.jss.2016.04.023",
language = "English (US)",
volume = "204",
pages = "8--14",
journal = "Journal of Surgical Research",
issn = "0022-4804",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - A policy of omitting an intensive care unit stay after robotic pancreaticoduodenectomy is safe and cost-effective

AU - Cunningham, Kellie E.

AU - Zenati, Mazen S.

AU - Petrie, Jonathan R.

AU - Steve, Jennifer L.

AU - Hogg, Melissa E.

AU - Zeh, Herbert J.

AU - Zureikat, Amer H.

PY - 2016/7/1

Y1 - 2016/7/1

N2 - Background Immediate postoperative admission to the intensive care unit (ICU) after pancreaticoduodenectomy (PD) is still a standard practice at many institutions. Our aim was to examine whether omission of an immediate postoperative ICU admission would be safe and result in improved outcomes and cost after robotic pancreaticoduodenectomy (RPD). Methods In December 2014, a non-ICU admission policy was implemented for patients undergoing RPD. Before this date, all RPDs were routinely admitted to the ICU on post operative day = 0. Using a prospective database, outcomes of the patients in the no-ICU cohort were compared with those of the patients routinely admitted to the ICU before implementation of this policy. Results The ICU (n = 49) and no-ICU cohorts (n = 47) were comparable in age, gender, body mass index, Charlson comorbidity index and American Society of Anesthesiologists scores, receipt of neoadjuvant therapy, operative time, estimated blood loss, tumor size, and pathologic diagnosis (all P values = NS). Clavien complications, pancreatic leak, reoperation, readmission, and mortality were similar between both the groups (all P values = NS). Hospital length of stay (LOS) was shorter for the no-ICU group (median 6.8 versus 7.7 d, P = 0.01). This reduced LOS and omission of routine postoperative ICU admission translated into a cost reduction from $23,933 (interquartile range $19,833-$28,991) in the ICU group to $19,516 (interquartile range $17,046-$23,893) in the no-ICU group, P = 0.004. The reduction in LOS and cost remained significant after adjusting for all related demographics and perioperative characteristics. Conclusions A standard policy of omitting a postoperative ICU admission on post operative day 0 after RPD is safe and can result in reduced LOS and overall savings in total hospital cost.

AB - Background Immediate postoperative admission to the intensive care unit (ICU) after pancreaticoduodenectomy (PD) is still a standard practice at many institutions. Our aim was to examine whether omission of an immediate postoperative ICU admission would be safe and result in improved outcomes and cost after robotic pancreaticoduodenectomy (RPD). Methods In December 2014, a non-ICU admission policy was implemented for patients undergoing RPD. Before this date, all RPDs were routinely admitted to the ICU on post operative day = 0. Using a prospective database, outcomes of the patients in the no-ICU cohort were compared with those of the patients routinely admitted to the ICU before implementation of this policy. Results The ICU (n = 49) and no-ICU cohorts (n = 47) were comparable in age, gender, body mass index, Charlson comorbidity index and American Society of Anesthesiologists scores, receipt of neoadjuvant therapy, operative time, estimated blood loss, tumor size, and pathologic diagnosis (all P values = NS). Clavien complications, pancreatic leak, reoperation, readmission, and mortality were similar between both the groups (all P values = NS). Hospital length of stay (LOS) was shorter for the no-ICU group (median 6.8 versus 7.7 d, P = 0.01). This reduced LOS and omission of routine postoperative ICU admission translated into a cost reduction from $23,933 (interquartile range $19,833-$28,991) in the ICU group to $19,516 (interquartile range $17,046-$23,893) in the no-ICU group, P = 0.004. The reduction in LOS and cost remained significant after adjusting for all related demographics and perioperative characteristics. Conclusions A standard policy of omitting a postoperative ICU admission on post operative day 0 after RPD is safe and can result in reduced LOS and overall savings in total hospital cost.

KW - Cost

KW - ICU

KW - Pancreaticoduodenectomy

KW - Robotic

KW - Whipple

UR - http://www.scopus.com/inward/record.url?scp=84969528626&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969528626&partnerID=8YFLogxK

U2 - 10.1016/j.jss.2016.04.023

DO - 10.1016/j.jss.2016.04.023

M3 - Article

C2 - 27451861

AN - SCOPUS:84969528626

VL - 204

SP - 8

EP - 14

JO - Journal of Surgical Research

JF - Journal of Surgical Research

SN - 0022-4804

IS - 1

ER -